Messenger RNA, or mRNA, is the central technology behind the rapid creation of the Pfizer and Moderna coronavirus vaccines. Known as cell-based vaccine technology, mRNA mimics the way cells generate proteins that activate immune responses. The process provides advantages over old vaccine production methods that relied on culturing viruses within eggs. Cell-based technology allows for increased vaccine efficacy and makes it possible for manufacturing facilities to produce multiple vaccine products at the same time.
Marriage of Biology and Computation Power
The scientific discipline of bioinformatics sequences DNA, which produces RNA messengers to carry out its functions. Modern advances in computational power speed this process and help researchers learn how to manipulate the immune response. As a result, scientists increasingly have the means of controlling dangerous viruses, like coronavirus and Ebola. In terms of vaccine production, the new method increases vaccine yields, purity, and potency.
The breakthroughs resulting from bioinformatics and mRNA will require a new generation of production equipment, including bioreactors and fermenters. Demand for such vaccines will be high around the world due to the devastation and economic disruption caused by outbreaks and pandemics.
Vast Potential Beyond Coronavirus
The coronavirus that causes Covid-19 has focused the global research and pharmaceutical industries on vaccine development and production. Science could bring many viruses under control, such as Zika, Epstein-Barr, or Lassa. The massive global efforts that delivered a coronavirus vaccine in under a year will also be called upon as new viruses emerge. Variations of influenza could threaten human populations at any time.
Higher Demand for Refrigeration Equipment
At this point, mRNA vaccines must be stored and transported at extremely low temperatures. The Pfizer vaccine must be kept at -70 Celsius, and the Moderna vaccine needs a temperature of -20 Celsius. Pfizer already maintains massive freezer farms for holding vaccines.
As the global population continues to cope with coronavirus and future threats, refrigeration manufacturers could experience greater demand for their products. Let us know if your industry expects additional business due to the ballooning growth of vaccine production.
We help protect as many people as possible from life-threatening illness with quality vaccines that make an impact across all stages of life by combining unrelenting passion, global impact, and an enduring quest for progress to unlock the promise and value that vaccines hold for our world.
Our passion for science, for delivering excellence, and for people’s health drive bold advancements in Research and Design (R&D) and high-quality manufacturing to consistently make a meaningful impact on public health. Passion drives our organization and permeates everything we do.
From our research scientists to our business operations teams, Pfizer Vaccines is comprised of passionate, world-class employees who work every day to translate cutting-edge science into next-generation vaccines that improve people’s lives.
Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease.
Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients.
We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed, and manufactured.
Since our founding in 2010, we have worked to build the industry’s leading mRNA technology platform, the infrastructure to accelerate drug discovery and early development, a rapidly expanding pipeline, and a world-class team.